• Login
    Search 
    •   Home
    • Scholarly Contributions
    • Public Health Sciences, Department of
    • Department of Public Health Sciences Graduate Theses
    • Search
    •   Home
    • Scholarly Contributions
    • Public Health Sciences, Department of
    • Department of Public Health Sciences Graduate Theses
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-4 of 4

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • xmlui.Discovery.AbstractSearch.sort_by.dc.date.available_dt_asc
    • xmlui.Discovery.AbstractSearch.sort_by.dc.date.available_dt_desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    The Association between the UGT2B17 Gene Deletion and Menopause-Related Quality of Life in Postmenopausal Women in the CCTG MAP.3 Breast Cancer Chemoprevention Trial 

    Knight, Braden
    Background: Mammary Prevention.3 (MAP.3) was a randomized placebo controlled trial of exemestane for breast cancer prevention. Participants commonly experienced vasomotor symptoms, such as hot flashes. Exemestane is ...
    Thumbnail

    UGT2B17, exemestane metabolism, and their association with physical health-related quality of life in Caucasian postmenopausal women participating in the Mammary Prevention.3 Trial 

    Basmadjian, Rob
    Background: In the Mammary Prevention.3 (MAP.3) trial of exemestane (EXE) for breast cancer prevention, postmenopausal women commonly reported physical menopause-related symptoms, such as joint and muscle pain and fatigue. ...
    Thumbnail

    Influence of the UGT2B17 Gene on the Relationship Between Exemestane and Bone Mineral Density in Postmenopausal Women 

    Bai, Sean
    Background: In the Mammary Prevention.3 (MAP.3) randomized placebo-controlled trial of exemestane, postmenopausal women experienced a loss in bone mineral density (BMD). UGT2B17 facilitates excretion of androgens and ...
    Thumbnail

    The associations between estrogens, the UGT2B17 gene deletion, and health-related quality of life in postmenopausal women in the MAP.3 chemoprevention trial 

    Cameron-Dermann, Lindsey
    Background: Natural depletions of estrogens during menopause are likely associated with symptoms and declines in health-related quality of life (HRQL). For women taking exemestane in the Mammary Prevention 3 (MAP.3) trial, ...

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us
    Theme by 
    Atmire NV
     

     

    Browse

    All of QSpaceCommunities & CollectionsPublished DatesAuthorsTitlesSubjectsTypesThis CollectionPublished DatesAuthorsTitlesSubjectsTypes

    My Account

    LoginRegister

    Discover

    AuthorBai, Sean (1)Basmadjian, Rob (1)Cameron-Dermann, Lindsey (1)Knight, Braden (1)Subject
    UGT2B17 (4)
    Exemestane (3)Breast Cancer (2)Chemoprevention (2)UGT2B17 Deletion (2)Aromatase Inhibitor (1)Bone (1)Bone Mineral Density (1)breast cancer (1)Breast cancer prevention (1)... View MoreDate Published2019 (2)2018 (1)2017 (1)

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us
    Theme by 
    Atmire NV